332 related articles for article (PubMed ID: 27997974)
1. The Microbiome and Primary Sclerosing Cholangitis.
Ali AH; Carey EJ; Lindor KD
Semin Liver Dis; 2016 Sep; 36(4):340-348. PubMed ID: 27997974
[TBL] [Abstract][Full Text] [Related]
2. New Therapeutic Strategies for Primary Sclerosing Cholangitis.
Williamson KD; Chapman RW
Semin Liver Dis; 2016 Feb; 36(1):5-14. PubMed ID: 26870928
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiome in primary sclerosing cholangitis: A review.
Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
[TBL] [Abstract][Full Text] [Related]
4. The management of primary sclerosing cholangitis.
Chapman RW
Curr Gastroenterol Rep; 2003 Feb; 5(1):9-17. PubMed ID: 12530943
[TBL] [Abstract][Full Text] [Related]
5. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value.
Li ZJ; Gou HZ; Zhang YL; Song XJ; Zhang L
World J Gastroenterol; 2022 Nov; 28(44):6213-6229. PubMed ID: 36504550
[TBL] [Abstract][Full Text] [Related]
6. Emerging treatments for primary sclerosing cholangitis.
Rodriguez EA; Carey EJ; Lindor KD
Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):451-459. PubMed ID: 28276816
[TBL] [Abstract][Full Text] [Related]
7. Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial.
Allegretti JR; Kassam Z; Carrellas M; Mullish BH; Marchesi JR; Pechlivanis A; Smith M; Gerardin Y; Timberlake S; Pratt DS; Korzenik JR
Am J Gastroenterol; 2019 Jul; 114(7):1071-1079. PubMed ID: 30730351
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.
Del Chierico F; Cardile S; Baldelli V; Alterio T; Reddel S; Bramuzzo M; Knafelz D; Lega S; Bracci F; Torre G; Maggiore G; Putignani L
Inflamm Bowel Dis; 2024 Apr; 30(4):529-537. PubMed ID: 37696680
[TBL] [Abstract][Full Text] [Related]
9. Manipulation of the Gut-Liver Axis Using Microbiome Restoration Therapy in Primary Sclerosing Cholangitis.
Bajaj JS; Hays RA
Am J Gastroenterol; 2019 Jul; 114(7):1027-1029. PubMed ID: 30920413
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.
Shah A; Macdonald GA; Morrison M; Holtmann G
Am J Gastroenterol; 2020 Jun; 115(6):814-822. PubMed ID: 32250997
[TBL] [Abstract][Full Text] [Related]
11. Primary sclerosing cholangitis: a clinical update.
Williamson KD; Chapman RW
Br Med Bull; 2015 Jun; 114(1):53-64. PubMed ID: 25981516
[TBL] [Abstract][Full Text] [Related]
12. Advances and controversies in the pathogenesis and management of primary sclerosing cholangitis.
Eksteen B
Br Med Bull; 2014 Jun; 110(1):89-98. PubMed ID: 24795363
[TBL] [Abstract][Full Text] [Related]
13. Microbial Players in Primary Sclerosing Cholangitis: Current Evidence and Concepts.
Özdirik B; Schnabl B
Cell Mol Gastroenterol Hepatol; 2024; 17(3):423-438. PubMed ID: 38109970
[TBL] [Abstract][Full Text] [Related]
14. Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis.
Lapidot Y; Amir A; Ben-Simon S; Veitsman E; Cohen-Ezra O; Davidov Y; Weiss P; Bradichevski T; Segev S; Koren O; Ben-Ari Z; Safran M
Hepatol Int; 2021 Feb; 15(1):191-201. PubMed ID: 32949377
[TBL] [Abstract][Full Text] [Related]
15. The Role of the Intestine in the Pathogenesis of Primary Sclerosing Cholangitis: Evidence and Therapeutic Implications.
Dean G; Hanauer S; Levitsky J
Hepatology; 2020 Sep; 72(3):1127-1138. PubMed ID: 32394535
[TBL] [Abstract][Full Text] [Related]
16. Current concepts in primary sclerosing cholangitis.
Wiesner RH
Mayo Clin Proc; 1994 Oct; 69(10):969-82. PubMed ID: 7934194
[TBL] [Abstract][Full Text] [Related]
17. Current Targets for Primary Sclerosing Cholangitis.
Pierantonelli I; Benedetti A; Marzioni M
Curr Drug Targets; 2017; 18(8):901-907. PubMed ID: 26758666
[TBL] [Abstract][Full Text] [Related]
18. Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies.
Tabibian JH; O'Hara SP; Lindor KD
Scand J Gastroenterol; 2014 Aug; 49(8):901-8. PubMed ID: 24990660
[TBL] [Abstract][Full Text] [Related]
19. Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies.
van Milligen de Wit AW; van Deventer SJ; Tytgat GN
Am J Gastroenterol; 1995 Jun; 90(6):893-900. PubMed ID: 7771416
[TBL] [Abstract][Full Text] [Related]
20. Primary sclerosing cholangitis.
Rodriguez HJ; Bass NM
Semin Gastrointest Dis; 2003 Oct; 14(4):189-98. PubMed ID: 14719769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
